|
|
Medicare Offerings |
As a reminder to our valued business partners,
As a reputable insurer, we monitor the insurance
landscape to ensure we offer insurance products that meet
customer needs and company priorities. As a result of this
ongoing process, we have made the decision to discontinue
Medicare Supplement sales for Equitable National effective
June 30, 2020.
Our Medicare Supplement customers and agents are
important to us and to our success. As a result and similar
to the announcement you may have received in recent weeks from
Equitable Life & Casualty, we are also transitioning some of
the administrative functions to Actuarial Management Resources
(AMR), an independent third party administrator, on August 1,
2020.
|
|
It is very important to note that this action
affects new sales only;
no
in-force policies will be cancelled or non-renewed due to the discontinuation of these plans.
Current policyowners may keep their policies for as long as they
wish by continuing their payment of premiums.
|
|
We will keep you updated over the next few months
as we work through these transitions. In the meantime, please
keep these important dates in mind:
May 29, 2020 – Last day we will contract and appoint new
agents with Equitable National.
June 30, 2020 –
Last day Medicare Supplement applications can be signed by you
and your clients.
July 15, 2020 –
Last day we will accept Medicare Supplement applications for
review and underwriting that were signed on or before June 30,
2020.
August 1, 2020 –
First day Actuarial Management Resources will begin providing
administrative services for the Equitable National Medicare
Supplement block. Please watch for future communication from us
with important updates.
We value our partnership with you and are
appreciative of the business you have placed with Equitable
National since 2017. We look forward to continuing to provide the
best service possible to you and your clients with Medicare
Supplement policies through Equitable National.
|
|
Vice President of Life & Health Operations
|
|
|
|
|
|
|
|